Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
27 September 2022
| COVID-19: Vaccines
Overview
These are the annexes to WHO interim recommendations for the use of the Novavax NVX-CoV2373 vaccine against COVID-19. Annexes 1–6 contain tables that summarize the grading of recommendations, assessment, development and evaluations (GRADE). Annexes 7–9 contain the SAGE evidence to recommendation framework tables (ETR tables). GRADE and ETR tables are updated as recommendations are updated.
WHO Team
Agenda, Policy & Strategy (APS),
Immunization, Vaccines and Biologicals (IVB),
Strategic Advisory Group of Experts on Immunization,
WHO Headquarters (HQ)
Number of pages
28
Reference numbers
ISBN: World Health Organization 2021. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO licence.
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/Novavax_NVX-CoV2373/annexes/2021.1
Copyright
